|
|
|
Insider
Information: |
Sachdev Amit |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
71,325 |
|
Indirect Shares
|
7,447 |
|
|
Direct
Value |
$26,276,609 |
|
|
Indirect Value
|
$3,536,953 |
|
|
Total
Shares |
78,772 |
|
|
Total
Value |
$29,813,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2016-02-03 |
4 |
AS |
$89.91 |
$923,460 |
D/D |
(10,166) |
86,096 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2021-02-11 |
4 |
AS |
$210.43 |
$939,068 |
D/D |
(4,460) |
63,542 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-03 |
4 |
AS |
$228.89 |
$946,845 |
D/D |
(4,097) |
36,190 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-01-23 |
4 |
AS |
$165.00 |
$960,960 |
D/D |
(5,824) |
39,163 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2023-02-17 |
4 |
D |
$292.85 |
$1,024,389 |
D/D |
(3,498) |
68,986 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-02-23 |
4 |
AS |
$43.60 |
$1,043,666 |
D/D |
(23,828) |
44,126 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Chief Patient & Ext Af Off |
|
2024-02-23 |
4 |
D |
$431.79 |
$1,066,090 |
D/D |
(2,469) |
58,329 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-03-30 |
4 |
AS |
$41.01 |
$1,089,308 |
D/D |
(26,562) |
33,608 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-11-25 |
4 |
AS |
$220.00 |
$1,100,000 |
D/D |
(5,000) |
33,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Chief Patient & Ext Af Off |
|
2024-02-20 |
4 |
D |
$420.58 |
$1,103,181 |
D/D |
(2,623) |
68,243 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-12-09 |
4 |
AS |
$225.00 |
$1,125,000 |
D/D |
(5,000) |
33,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-01-22 |
4 |
OE |
$83.36 |
$1,146,200 |
D/D |
13,750 |
52,913 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-01-08 |
4 |
AS |
$230.00 |
$1,150,000 |
D/D |
(5,000) |
36,190 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-07-13 |
4 |
OE |
$96.87 |
$1,165,443 |
D/D |
12,031 |
58,693 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-12 |
4 |
OE |
$33.28 |
$1,256,235 |
D/D |
37,500 |
66,487 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Chief Patient & Ext Af Off |
|
2024-02-26 |
4 |
AS |
$425.70 |
$1,278,803 |
D/D |
(3,004) |
55,325 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-03-09 |
4 |
OE |
$96.87 |
$1,331,963 |
D/D |
13,750 |
60,412 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Chief Patient & Ext Af Off |
|
2024-02-21 |
4 |
AS |
$421.77 |
$1,345,868 |
D/D |
(3,191) |
60,798 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Chief Patient & Ext Af Off |
|
2024-02-12 |
4 |
AS |
$420.24 |
$1,354,013 |
D/D |
(3,222) |
74,364 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-01-29 |
4 |
OE |
$91.05 |
$1,373,489 |
D/D |
15,085 |
54,248 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2014-10-28 |
4 |
AS |
$115.00 |
$1,380,000 |
D/D |
(12,000) |
38,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-07-21 |
4 |
AS |
$158.05 |
$1,386,691 |
D/D |
(8,625) |
90,710 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2023-02-13 |
4 |
D |
$298.26 |
$1,388,997 |
D/D |
(4,657) |
72,484 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-11 |
4 |
OE |
$131.89 |
$1,406,607 |
D/D |
10,665 |
45,768 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2014-06-24 |
4 |
OE |
$33.28 |
$1,420,998 |
D/D |
42,250 |
80,921 |
0 |
- |
|
193 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|